Stock CYCLACEL PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Cyclacel Pharmaceuticals Inc Nasdaq

Equities

US23254L1089

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Cyclacel Pharmaceuticals Inc
Jun. 26 Sector Update: Health Care Stocks Softer Late Afternoon MT
Jun. 26 Sector Update: Health Care Stocks Lower in Afternoon Trading MT

Chart calendar Cyclacel Pharmaceuticals Inc

9d119a.Rdcaru_aL4SNtrxhrR8JCDHSukPI7qTf4kY0f155O0g.DeJMwp6UdeDX3I0Vykd5ZVeI1wGp1pKl1QkZNjg_dxpo5m_lnrJE0rzgyw~b07c5fba252c4868c0a8988475470968

Upcoming events on Cyclacel Pharmaceuticals Inc

2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-12 Q3 2024 Earnings Release (Projected)
2025-03-31 Q4 2024 Earnings Release (Projected)
2025-05-19 Q1 2025 Earnings Release (Projected)

Past events on Cyclacel Pharmaceuticals Inc

2024-06-21 11:00 am Annual General Meeting
2024-06-01 02:30 pm American Society of Clinical Oncology Meeting - Abstract No - 3596
2024-05-31 06:30 pm American Society of Clinical Oncology Meeting - Abstract No: 3125
2024-05-14 04:30 pm Q1 2024 Earnings Call
2024-05-14 04:05 pm Q1 2024 Earnings Release
2024-04-09 04:30 pm American Association for Cancer Research Meeting - Abstract No: 5711 / 11
2024-04-08 12:00 pm American Association for Cancer Research Meeting - Abstract No: 2117 / 8
2024-04-07 04:30 pm American Association for Cancer Research Meeting - Abstract No: 518 / 15
2024-03-19 04:30 pm Q4 2023 Earnings Call
2024-03-19 04:05 pm Q4 2023 Earnings Release
2024-03-16 Roth Conference
2024-02-26 02:30 pm BIO CEO & Investor Conference
2024-01-08 02:00 pm Biotech Showcase
2023-12-17 Reverse Split: 1 of 15
2023-12-08 09:30 am Extraordinary Shareholders Meeting
2023-11-13 04:30 pm Q3 2023 Earnings Call
2023-11-13 04:05 pm Q3 2023 Earnings Release
2023-08-09 04:30 pm Q2 2023 Earnings Call
2023-08-09 04:05 pm Q2 2023 Earnings Release
2023-06-13 12:00 pm Annual General Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,42
0,39
7.97%
0,06

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-9,68
-9,42
-2.75%		-10,6
-10,2
-4.7%		-22,9
-23,1
0.75%		-27,7
-25,7
-7.71%		-25,5
-26,3
3.24%
-15,7

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,13
-8,88
-2.82%		-9,68
-9,25
-4.68%		-22,7
-23,0
1.22%		-25,9
-24,4
-6.29%		-25,6
-26,1
2.17%
-15,6

Net income
Million USD		Released
Forecast
Spread 		-8,03
-7,99
-0.49%		-12,4
-8,41
-47.43%		-19,1
-20,4
6.36%		-21,4
-21,3
-0.4%		-22,8
-23,2
1.72%
-12,9

EPS
USD		Released
Forecast
Spread 		-150
-153
1.96%		-51,3
-38,4
-33.42%		-32,1
-34,6
7.16%		-28,5
-26,7
-6.74%		-26,8
-20,2
-32.25%
-4,93

Announcement Date26/02/2025/02/2128/03/2206/03/2319/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,37
0,00
- 		0,02
0,00
- 		0,03
0,00
- 		0,03
0,00
-
0,02


0,02


0,02

EBIT
Million USD		Released
Forecast
Spread 		-6,56
-7,15
8.3%		-5,79
-6,98
17.08%		-6,47
-6,79
4.8%		-8,85
-6,94
-27.53%		-7,32
-9,28
21.1%		-5,93
-7,12
16.78%		-6,85
-5,99
-14.3%		-5,36
-6,21
13.73%		-4,36
-5,57
21.88%
-4,03


-3,76


-3,57

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-5,25
-7,27
27.88%		-5,56
-7,07
21.4%		-6,11
-6,83
10.5%		-9,00
-6,78
-32.68%		-7,12
-9,29
23.3%		-6,03
-7,26
16.94%		-6,70
-5,82
-15.16%		-5,69
-6,21
8.31%		-4,30
-6,56
34.46%
-4,01


-3,73


-3,54

Net income
Million USD		Released
Forecast
Spread 		-4,16
-7,07
41.17%		-4,63
-5,66
18.24%		-5,15
-6,37
19.27%		-7,47
-6,54
-14.15%		-5,85
-8,42
30.43%		-5,50
-6,59
16.63%		-6,15
-5,26
-16.97%		-5,32
-5,70
6.61%		-2,95
-6,06
51.39%
-3,51


-3,30


-3,12

EPS
USD		Released
Forecast
Spread 		-6,30
-10,3
38.69%		-6,90
-8,06
14.42%		-6,30
-7,65
17.65%		-9,00
-7,24
-24.35%		-7,05
-9,95
29.15%		-6,60
-7,55
12.58%		-7,35
-5,45
-34.86%		-6,23
-5,89
-5.71%		-2,27
-4,75
52.16%
-1,44


-1,14


-0,80

Announcement Date11/05/2210/08/2209/11/2206/03/2311/05/2309/08/2313/11/2319/03/2414/05/24---

Upcoming sector events for Cyclacel Pharmaceuticals Inc

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 EXELIXIS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Cyclacel Pharmaceuticals Inc

2024-07-11 04:00 pm NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release
2024-07-04 PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release
2024-06-05 03:51 am PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
2024-05-17 07:00 am AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
2024-05-15 08:05 am THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. CYCC Stock
  4. Stock
  5. Calendar Cyclacel Pharmaceuticals Inc